Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.4 to v3.6.5, indicating a site update. The study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-08-11T14:43:18.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Updated study timeline dates: primary completion now 2026-12-30 and study completion now 2027-06-28. A new Revision: v3.6.4 tag appears, indicating an updated page version.
    Difference
    0.3%
    Check dated 2026-07-28T05:33:44.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.2 to v3.6.3, indicating a new build of the ClinicalTrials.gov page. This change typically reflects maintenance updates and does not alter the study data or eligibility details.
    Difference
    0.0%
    Check dated 2026-07-06T16:46:08.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page's revision line now shows Revision: v3.6.2, replacing the previous v3.6.0. This indicates a newer version of the page has been published.
    Difference
    0.0%
    Check dated 2026-06-29T08:50:41.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The Study Details page now states that no participants are being recruited, reflecting the current enrollment status. New help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' appear, and the Intervention/Treatment header is updated under Revision: v3.6.0, replacing the previous label.
    Difference
    0.4%
    Check dated 2026-06-15T05:28:26.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a small update to the page rendering.
    Difference
    0.0%
    Check dated 2026-06-08T04:11:50.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.